Folia Neuropathologica

Full text

3/2026 vol. 64
Review paper

Docosahexaenoic acid and Alzheimer’s disease: a systematic review

Syed Adnan Rahmat 1
,
Arshad Mehmood 2
,
Naif Almakayeel 3
,
Ghada Moh. Samir Elhessewi 4
,
Meshal Shutaywi 5
,
Xuemei Wang 2

  1. Cancer Institute, The Fourth Hospital of Hebei Medical University/The Tumor Hospital of Hebei Province, Shijiazhuang, China

  2. State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China

  3. Department of Industrial Engineering, College of Engineering, King Khalid University, Abha, 61421, Saudi Arabia

  4. Department of Health Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia

  5. Department of Mathematics, Faculty of Science & Arts, King Abdul Aziz University, Rabigh, Saudi Arabia

Folia Neuropathol 2026; 64 (3): 213-224

DOI: https://doi.org/10.5114/fn.2026.165797
Data publikacji online: 2026/10/26
Article file
FN Docosahexaenoic acid.pdf
  1. Abu-El-Rub E, Khasawneh RR, Almahasneh FA, Aloud BM, Zegallai HM. The molecular and functional changes of neural stem cells in Alzheimer’s disease: can they be reinvigorated to conduct neurogenesis. Curr Stem Cell Res Ther 2023; 18: 580-594.
  2. Amza M, Haj Hamoud B, Sima RM, Dinu MD, Gorecki GP, Popescu M, Gică N, Poenaru MO, Pleș L. Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)-should they be mandatory supplements in pregnancy? Biomedicines 2024; 12: 1471.
  3. Arab K, Rossary A, Flourié F, Tourneur Y, Steghens JP. Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating gamma-glutamyl-cysteinyl ligase and glutathione reductase. Br J Nutr 2006; 95: 18-26.
  4. Bach SA, de Siqueira LV, Müller AP, Oses JP, Quatrim A, Emanuelli T, Vinadé L, Souza DO, Moreira JD. Dietary omega-3 deficiency reduces BDNF content and activation NMDA receptor and Fyn in dorsal hippocampus: implications on persistence of long-term memory in rats. Nutr Neurosci 2014; 17: 186-192.
  5. Badesso S, Cartas-Cejudo P, Espelosin M, Santamaria E, Cuadrado-Tejedor M, Garcia-Osta A. Docosahexaenoic acid ameliorates contextual fear memory deficits in the Tg2576 Alzheimer’s disease mouse model: cellular and molecular correlates. Pharmaceutics 2022; 15: 82.
  6. Bang S, Song JK, Lee KH. Hyperphosphorylated tau targeting human serum albumin Fusion protein as therapeutics for Alzheimer’s diseases. IBRO Neurosci Rep 2024; 17: 423-430.
  7. Basak S, Mallick R, Duttaroy AK. Maternal docosahexaenoic acid status during pregnancy and its impact on infant neurodevelopment. Nutrients 2020; 12: 3615.
  8. Berdugo-Vega G, Arias-Gil G, López-Fernández A, Artegiani B, Wasielewska JM, Lee CC, Lippert MT, Kempermann G, Takagaki K, Calegari F. Increasing neurogenesis refines hippocampal activity rejuvenating navigational learning strategies and contextual memory throughout life. Nat Commun 2020; 11: 135.
  9. Bie N, Li J, Li C, Lian R, Qin L, Wang C. Protective effect and mechanism of docosahexaenoic acid on the cognitive function in female APP/PS1 mice. Food Funct 2021; 12: 11435-11448.
  10. Bonafina A, Paratcha G, Ledda F. Deciphering new players in the neurogenic adult hippocampal niche. Front Cell Dev Biol 2020; 8: 548.
  11. Borgonovi SM, Iametti S, Di Nunzio M. Docosahexaenoic acid as master regulator of cellular antioxidant defenses: a systematic review. Antioxidants (Basel) 2023; 12: 1283.
  12. Breton J, Robertson EM. Memory processing: the critical role of neuronal replay during sleep. Curr Biol 2013; 23: R836-R838.
  13. Broadhurst CL, Cunnane SC, Crawford MA. Rift Valley lake fish and shellfish provided brain-specific nutrition for early Homo. Br J Nutr 1998; 79: 3-21.
  14. Burns-Whitmore B, Froyen E, Heskey C, Parker T, San Pablo G. Alpha-linolenic and linoleic fatty acids in the vegan diet: do they require dietary reference intake/adequate intake special consideration? Nutrients 2019; 11: 2365.
  15. Cardoso C, Afonso C, Bandarra NM. Dietary DHA and health: cognitive function ageing. Nutr Res Rev 2016; 29: 281-294.
  16. Cebrian-Silla A, Nascimento MA, Redmond SA, Mansky B, Wu D, Obernier K, Romero Rodriguez R, Gonzalez-Granero S, García-Verdugo JM, Lim DA, Álvarez-Buylla A. Single-cell analysis of the ventricular-subventricular zone reveals signatures of dorsal and ventral adult neurogenesis. Elife 2021; 10: e67436.
  17. Chen X, Juarez A, Mason S, Kobayashi S, Baker SL, Harrison TM, Landau SM, Jagust WJ. Longitudinal relationships between Ab and tau to executive function and memory in cognitively normal older adults. Neurobiol Aging 2025; 145: 32-41.
  18. Cholewski M, Tomczykowa M, Tomczyk M. A comprehensive review of chemistry, sources and bioavailability of omega-3 fatty acids. Nutrients 2018; 10: 1662.
  19. Cole GM, Frautschy SA. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer’s disease mouse model. Nutr Health 2006; 18: 249-259.
  20. de Santis A, Vitiello G, Appavou MS, Scoppola E, Fragneto G, Barnsley LC, Clifton LA, Ottaviani MF, Paduano L, Russo Krauss I, D’Errico G. Not just a fluidifying effect: omega-3 phospholipids induce formation of non-lamellar structures in biomembranes. Soft Matter 2020; 16: 10425-10438.
  21. Denis I, Potier B, Heberden C, Vancassel S. Omega-3 polyunsaturated fatty acids and brain aging. Curr Opin Clin Nutr Metab Care 2015; 18: 139-146.
  22. Deshmukh GV, Niaz H, Bai R, Kim DH, Kim JW, Asghar J, Ramzan T, Maqbool M, Abushalha NB, Arif S, Khan S. The role of omega-3 fatty acid supplementation in slowing cognitive decline among elderly patients with Alzheimer’s disease: a systematic review of randomized controlled trials. Cureus 2024; 16: e73390.
  23. Díaz M, Mesa-Herrera F, Marín R. DHA and Its elaborated modulation of antioxidant defenses of the brain: implications in aging and AD neurodegeneration. Antioxidants (Basel) 2021; 10: 907.
  24. Echeverría F, Valenzuela R, Catalina Hernandez-Rodas M, Valenzuela A. Docosahexaenoic acid (DHA), a fundamental fatty acid for the brain: New dietary sources. Prostaglandins Leukot Essent Fatty Acids 2017; 124: 1-10.
  25. Farioli-Vecchioli S, Saraulli D, Costanzi M, Pacioni S, Cinà I, Aceti M, Micheli L, Bacci A, Cestari V, Tirone F. The timing of differentiation of adult hippocampal neurons is crucial for spatial memory. PLoS Biol 2008; 6: e246.
  26. Favrelière S, Perault MC, Huguet F, De Javel D, Bertrand N, Piriou A, Durand G. DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus. Neurobiol Aging 2003; 24: 233-243.
  27. Frey L, Hiller S, Riek R, Bibow S. Lipid- and cholesterol-mediated time-scale-specific modulation of the outer membrane protein X dynamics in lipid bilayers. J Am Chem Soc 2018; 140: 15402-15411.
  28. Gharami K, Das M, Das S. Essential role of docosahexaenoic acid towards development of a smarter brain. Neurochem Int 2015; 89: 51-62.
  29. Giner-Robles L, Lázaro B, de la Cruz F, Moncalián G. fabH deletion increases DHA production in Escherichia coli expressing Pfa genes. Microb Cell Fact 2018; 17: 88.
  30. Gourley SL, Kedves AT, Olausson P, Taylor JR. A history of corticosterone exposure regulates fear extinction and cortical NR2B, GluR2/3, and BDNF. Neuropsychopharmacology 2009; 34: 707-716.
  31. Greupner T, Kutzner L, Nolte F, Strangmann A, Kohrs H, Hahn A, Schebb NH, Schuchardt JP. Effects of a 12-week high-a-linolenic acid intervention on EPA and DHA concentrations in red blood cells and plasma oxylipin pattern in subjects with a low EPA and DHA status. Food Funct 2018; 9: 1587-1600.
  32. Gu JL, Liu F. Tau in Alzheimer’s disease: Pathological alterations and an attractive therapeutic target. Curr Med Sci 2020; 40: 1009-1021.
  33. Hachem M, Ali AH, Hejou M, Almansoori A, Abulhassan S, Hussein F, Khalifa R, Khalifa R, Corridon PR. Sustainable and biotechnological production of docosahexaenoic acid from marine protists and slaughterhouse waste. Crit Rev Biotechnol 2025; 45: 1634-1651.
  34. Hajjar T, Goh YM, Rajion MA, Vidyadaran S, Li TA, Ebrahimi M. Alterations in neuronal morphology and synaptophysin expression in the rat brain as a result of changes in dietary n-6: n-3 fatty acid ratios. Lipids Health Dis 2013; 12: 113.
  35. Hajjar T, Meng GY, Rajion MA, Vidyadaran S, Othman F, Far- jam AS, Li TA, Ebrahimi M. Omega 3 polyunsaturated fatty acid improves spatial learning and hippocampal peroxisome proliferator activated receptors (PPARa and PPARg) gene expression in rats. BMC Neurosci 2012; 13: 109.
  36. Hashimoto M, Hossain S, Al Mamun A, Matsuzaki K, Arai H. Docosahexaenoic acid: one molecule diverse functions. Crit Rev Biotechnol 2017; 37: 579-597.
  37. Hashimoto M, Hossain S, Katakura M, Mamun AA, Shido O. Docosahexaenoic acid helps to lessen extinction memory in rats. Molecules 2018; 23: 451.
  38. Henjum S, Lie Ø, Ulak M, Thorne-Lyman AL, Chandyo RK, Shrestha PS, W Fawzi W, Strand TA, Kjellevold M. Erythrocyte fatty acid composition of Nepal breast-fed infants. Eur J Nutr 2018; 57: 1003-1013.
  39. Henzen NA, Abdulkadir A, Reinhardt J, Blatow M, Kressig RW, Krumm S. Automated segmentation for cortical thickness of the medial perirhinal cortex. Sci Rep 2025; 15: 14903.
  40. Hiskens MI. Glua1 ubiquitination in synaptic plasticity and cognitive functions: implications for neurodegeneration. J Neuro- sci 2024; 44: e2018232024.
  41. Hoffman DR, Boettcher JA, Diersen-Schade DA. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 151-158.
  42. Huang J, Wang X, Xie L, Wu M, Zhao W, Zhang Y, Wang Q, Yao L, Li W. Extract of Danggui-Shaoyao-San ameliorates cognition deficits by regulating DHA metabolism in APP/PS1 mice. J Ethnopharmacol 2020; 253: 112673.
  43. Khandelwal S, Kondal D, Gupta R, Chaudhry M, Dutta S, Ramakrishnan L, Patil K, Swamy MK, Prabhakaran D, Tandon N, Ramakrishnan U, Stein AD. Docosahexaenoic acid supplementation in lactating women increases breast milk and erythrocyte membrane docosahexaenoic acid concentrations and alters infant n-6:n-3 fatty acid ratio. Curr Dev Nutr 2023; 7: 102010.
  44. Kim HY, Huang BX, Spector AA. Molecular and signaling mechanisms for docosahexaenoic acid-derived neurodevelopment and neuroprotection. Int J Mol Sci 2022; 23: 4635.
  45. Kim HY, Spector AA. N-Docosahexaenoylethanolamine: A neurotrophic and neuroprotective metabolite of docosahexaenoic acid. Mol Aspects Med 2018; 64: 34-44.
  46. Labrador-Espinosa MA, Silva-Rodríguez J, Reina-Castillo MI, Mir P, Grothe MJ. Basal forebrain atrophy, cortical thinning, and amyloid-b status in Parkinson’s disease-related cognitive decline. Mov Disord 2023; 38: 1871-1880.
  47. Lei E, Vacy K, Boon WC. Fatty acids and their therapeutic potential in neurological disorders. Neurochem Int 2016; 95: 75-84.
  48. Li J, Pora BLR, Dong K, Hasjim J. Health benefits of docosahexaenoic acid and its bioavailability: A review. Food Sci Nutr 2021; 9: 5229-5243.
  49. Lin PY, Cheng C, Satyanarayanan SK, Chiu LT, Chien YC, Chuu CP, Lan TH, Su KP. Omega-3 fatty acids and blood-based biomarkers in Alzheimer’s disease and mild cognitive impairment: A randomized placebo-controlled trial. Brain Behav Immun 2022; 99: 289-298.
  50. Lo Van A, Hachem M, Lagarde M, Bernoud-Hubac N. Omega-3 docosahexaenoic acid is a mediator of fate-decision of adult neural stem cells. Int J Mol Sci 2019; 20: 4240.
  51. Lüscher C, Malenka RC. NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). Cold Spring Harb Perspect Biol 2012; 4: a005710.
  52. Macaron T, Giudici KV, Bowman GL, Sinclair A, Stephan E, Vellas B, de Souto Barreto P. Associations of omega-3 fatty acids with brain morphology and volume in cognitively healthy older adults: A narrative review. Ageing Res Rev 2021; 67: 101300.
  53. Mancini A, de Iure A, Picconi B. Basic mechanisms of plasticity and learning. Handb Clin Neurol 2022; 184: 21-34.
  54. Mariamenatu AH, Abdu EM. Overconsumption of omega-6 polyunsaturated fatty acids (PUFAs) versus deficiency of omega-3 PUFAs in modern-day diets: the disturbing factor for their “balanced antagonistic metabolic functions” in the human body. J Lipids 2021; 2021: 8848161.
  55. Mello-Sampayo C, Pádua MS, Silva MR, Lourenço M, Pinto RMA, Carvalho S, Correia J, Martins CF, Gomes R, Gomes-Bispo A, Afonso C, Cardoso C, Bandarra N, Lopes PA. Neuronal count, brain injury, and sustained cognitive function in 5×FAD Alzheimer’s disease mice fed DHA-enriched diets. Biomolecules 2025; 15: 1164.
  56. Michno W, Stringer KM, Enzlein T, Passarelli MK, Escrig S, Vitanova K, Wood J, Blennow K, Zetterberg H, Meibom A, Hopf C, Edwards FA, Hanrieder J. Following spatial Aβ aggregation dynamics in evolving Alzheimer’s disease pathology by imaging stable isotope labeling kinetics. Sci Adv 2021; 7: eabg4855.
  57. Milla C, Widodo, Wardhana TH. The hidden and complex relationship between dietary phosphorus and malnutrition in hemodialysis patients with chronic kidney disease. Rom J Intern Med 2024; 62: 52-60.
  58. Miranda A, Montiel E, Ulrich H, Paz C. Selective secretase targeting for Alzheimer’s disease therapy. J Alzheimers Dis 2021; 81: 1-17.
  59. Morrow AL, Dawodu A. Fatty acids and fat-soluble vitamins in breast milk: physiological significance and factors affecting their concentrations. Nestle Nutr Inst Workshop Ser 2019; 90: 57-67.
  60. Naffaa MM. Neurogenesis dynamics in the olfactory bulb: deciphering circuitry organization, function, and adaptive plasticity. Neural Regen Res 2025; 20: 1565-1581.
  61. Nelson B, Lavoie S, Gawęda Ł, Li E, Sass LA, Koren D, McGorry PD, Jack BN, Parnas J, Polari A, Allott K, Hartmann JA, Whitford TJ. The neurophenomenology of early psychosis: An integrative empirical study. Conscious Cogn 2020; 77: 102845.
  62. Nury T, Doria M, Lizard G, Vejux A. Docosahexaenoic acid attenuates mitochondrial alterations and oxidative stress leading to cell death induced by very long-chain fatty acids in a mouse oligodendrocyte model. Int J Mol Sci 2020; 21: 641.
  63. O’Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci 2011; 34: 185-204.
  64. Oliveira-Filho RS, Torrinhas RS, Tesser A, Sampaio GR, Torres E, Garla PC, Waitzberg DL. Effect of a parenteral fish-oil-containing lipid emulsion on liver lipid perioxidation and antioxidative defenses in Lewis rats. JPEN J Parenter Enteral Nutr 2023; 47: 572-579.
  65. Oster T, Pillot T. Docosahexaenoic acid and synaptic protection in Alzheimer’s disease mice. Biochim Biophys Acta 2010; 1801: 791-798.
  66. Otaegui L, Urgin T, Zaiter T, Zussy C, Vitalis M, Pellequer Y, Acar N, Vigor C, Galano JM, Durand T, Givalois L, Béduneau A, Desrumaux C. Nose-to-brain delivery of DHA-loaded nanoemulsions: A promising approach against Alzheimer’s disease. Int J Pharm 2025; 670: 125125.
  67. Oye Mintsa Mi-Mba MF, Lebbadi M, Alata W, Julien C, Emond V, Tremblay C, Fortin S, Barrow CJ, Bilodeau JF, Calon F. Differential impact of eicosapentaenoic acid and docosahexaenoic acid in an animal model of Alzheimer’s disease. J Lipid Res 2024; 65: 100682.
  68. Pan Y, Choy KHC, Marriott PJ, Chai SY, Scanlon MJ, Porter CJH, Short JL, Nicolazzo JA. Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets. J Neurochem 2018; 144: 81-92.
  69. Pandey K, Srivastava P, Pandey SK, Johari S, Bhatnagar P, Sona- ne M, Mishra A. Stem cells as a novel source for regenerative medicinal applications in Alzheimer’s disease: An update. Curr Mol Med 2025; 25: 146-166.
  70. Park HA, Crowe-White KM, Ciesla L, Scott M, Bannerman S, Davis AU, Adhikari B, Burnett G, Broman K, Ferdous KA, Lac- key KH, Licznerski P, Jonas EA. Alpha-tocotrienol enhances arborization of primary hippocampal neurons via upregulation of Bcl-xL. Nutr Res 2022; 101: 31-42.
  71. Pietrzak-Wawrzyńska BA, Wnuk A, Przepiórska-Drońska K, Łach A, Kajta M. Posttreatment with PaPE-1 protects from Ab-induced neurodegeneration through inhibiting the expression of Alzheimer’s disease-related genes and apoptosis process that involves enhanced DNA methylation of specific genes. Mol Neurobiol 2024; 61: 4130-4145.
  72. Plascencia-Villa G, Perry G. Roles of oxidative stress in synaptic dysfunction and neuronal cell death in Alzheimer’s disease. Antioxidants (Basel) 2023; 12: 1628.
  73. Rahimi Darehbagh R, Seyedoshohadaei SA, Ramezani R, Rezaei N. Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives. Eur J Med Res 2024; 29: 386.
  74. Ramos-Riera KP, Pérez-Severiano F, López-Meraz ML. Oxidative stress: a common imbalance in diabetes and epilepsy. Metab Brain Dis 2023; 38: 767-782.
  75. Richard C, Calder PC. Docosahexaenoic acid. Adv Nutr 2016; 7: 1139-1141.
  76. Ripperger HS, Reed RG, Kang C, Lesnovskaya A, Aghjayan SL, Huang H, Wan L, Sutton BP, Oberlin L, Collins AM, Burns JM, Vidoni ED, Kramer AF, McAuley E, Hillman CH, Grove GA, Jaki- cic JM, Erickson KI. Cardiorespiratory fitness, hippocampal subfield morphology, and episodic memory in older adults. Front Aging Neurosci 2024; 16: 1466328.
  77. Roy K, Dvorak P, Machova Z, Mraz J. Nutrient footprint versus EPA + DHA security in land-locked regions-more of local pond farmed, imported marine fish or fish oil capsules? NPJ Sci Food 2023; 7: 48.
  78. Shaffer J. Neuroplasticity and clinical practice: building brain power for health. Front Psychol 2016; 7: 1118.
  79. Sherratt SCR, Libby P, Bhatt DL, Mason RP. Comparative effects of mineral oil, corn oil, eicosapentaenoic acid, and docosahexaenoic acid in an in vitro atherosclerosis model. J Am Heart Assoc 2023; 12: e029109.
  80. Sijtsma L, de Swaaf ME. Biotechnological production and applications of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. Appl Microbiol Biotechnol 2004; 64: 146-153.
  81. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A 1998; 95: 6460-6464.
  82. Sinclair AJ. Docosahexaenoic acid and the brain- what is its role? Asia Pac J Clin Nutr 2019; 28: 675-688.
  83. Thomas Rajarethnem H, Megur Ramakrishna Bhat K, Jc M, Kumar Gopalkrishnan S, Mugundhu Gopalram RB, Rai KS. Combined supplementation of choline and docosahexaenoic acid during pregnancy enhances neurodevelopment of fetal hippocampus. Neurol Res Int 2017; 2017: 8748706.
  84. Umebayashi M, Takemoto S, Reymond L, Sundukova M, Hovius R, Bucci A, Heppenstall PA, Yokota H, Johnsson K, Riezman H. A covalently linked probe to monitor local membrane properties surrounding plasma membrane proteins. J Cell Biol 2023; 222: e202206119.
  85. Welty FK. Omega-3 fatty acids and cognitive function. Curr Opin Lipidol 2023; 34: 12-21.
  86. Wojdasiewicz P, Poniatowski ŁA, Turczyn P, Frasuńska J, Paradowska-Gorycka A, Tarnacka B. Significance of omega-3 fatty acids in the prophylaxis and treatment after spinal cord injury in rodent models. Mediators Inflamm 2020; 2020: 3164260.
  87. Xia D, Li C, Götz J. Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines. Biochim Biophys Acta 2015; 1852: 913-924.
  88. Xiang X, Jiang X, Lin H, Yu M, Wu L, Zhou R. Acylhydrazone derivative A5 promotes neurogenesis by up-regulating neurogenesis-related genes and inhibiting cell-cycle progression in neural stem/progenitor cells. Molecules 2024; 29: 3330.
  89. Xiao M, Xiang W, Chen Y, Peng N, Du X, Lu S, Zuo Y, Li B, Hu Y, Li X. DHA ameliorates cognitive ability, reduces amyloid deposition, and nerve fiber production in Alzheimer’s disease. Front Nutr 2022; 9: 852433.
  90. Xiao M, Yao C, Liu F, Xiang W, Zuo Y, Feng K, Lu S, Xiang L, Li M, Li X, Du X. Sialic acid ameliorates cognitive deficits by reducing amyloid deposition, nerve fiber production, and neuronal apoptosis in a mice model of Alzheimer’s disease. NeuroSci 2021; 3: 28-40.
  91. Yurko-Mauro K. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. Curr Alzheimer Res 2010; 7: 190-196.
  92. Zhou D, Liu H, Li C, Wang F, Shi Y, Liu L, Zhao X, Liu A, Zhang J, Wang C, Chen Z. Atorvastatin ameliorates cognitive impairment, Ab1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice. Metab Brain Dis 2016; 31: 693-703.
Copyright: © 2026 Mossakowski Medical Research Centre Polish Academy of Sciences and the Polish Association of Neuropathologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications